Lung cancer (LC) is currently a major leading cause of cancer deaths worldwide. Poly(ADPribose) polymerases (PARP)-1 and -2 play important roles in DNA repair and other cell functions. Oxidative stress triggers autophagy and apoptosis. PARP inhibitors are currently used as anticancer strategies including LC. We hypothesized that inhibition of either PARP-1 or -2 expressions in the host animals influences tumor burden through several biological mechanisms, mainly redox imbalance (enhanced oxidative stress and/or decreased antioxidants, and cell regulators) in wild type (WT) lung adenocarcinoma cells. Compared to WT control tumors, in those of Parp-1 -/-and Parp-2 -/-mice: 1) tumor burden, as measured by weight, and cell proliferation rates were decreased, 2) oxidative stress levels were greater, whereas those of the major antioxidant enzymes were lower especially catalase, 3) tumor apoptosis and autophagy levels were significantly increased, and 4) miR-223 and nuclear factor of activated T-cells (NFAT)c-2 expression was decreased (the latter only in Parp-1 -/-mice). Furthermore, whole body weight gain at the end of the study period also improved in Parp-1 -/-and Parp-2 -/-mice compared to WT animals. We conclude that PARP-1 and -2 genetic deletions in the host mice induced a significant reduction in tumor burden most likely through alterations in redox balance (downregulation of antioxidants, NFATc-2 and miR223, and increased oxidative stress), which in turn led to increased apoptosis and autophagy.
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INTRODUCTION
Lung cancer (LC) is the most prevalent cancer nowadays. Moreover, it is the leading cause of cancer deaths worldwide, with an overall survival rate lower than 15% in five years [1, 2] .
Cigarette smoke and other noxious particles that promote lung carcinogenesis are probably the main etiologic factors of LC [3, 4] . Despite that the study of LC has received much attention in the last years, the lack of appropriate methodologies for the early diagnosis together with the absence of safe targeted therapies, are probably the main reasons accounting for its poor prognosis [5] [6] [7] [8] [9] [10] .
Poly(ADP-ribosyl)ation is a posttranscriptional modification by which poly(ADPribose) polymerases (PARPs) polymerize poly(ADP-ribose) on acceptor proteins using NAD + as a substrate [11] . PARP-1 and PARP-2 are the most relevant components of the base excision repair system, and repair single-stranded DNA breaks, thus maintaining genome stability [12] . Additionally, PARP-1 and PARP-2 also participate in other biological functions such as angiogenesis and transcription [12, 13] , apoptosis of oxidative-stress related pathologies [14] [15] [16] , and regulation of the immune response [11, 12] . On the other hand, an increased activity or overexpression of PARP-1 and -2 may also induce cellular damage by depleting the ATP stores of cells in several conditions [17] [18] [19] [20] or by altering the mechanisms of DNA repair, leading to tumorogenesis of several cancer types [12, [21] [22] [23] [24] . Therefore, the role of PARP-1 and PARP-2 in cells is two-fold: while they play a critical role in DNA repair, they may also favor carcinogenesis and tumor progression [12, [21] [22] [23] [24] [25] . In line with the latter, PARP-1 overexpression was also shown to correlate with poor survival of patients with breast cancer [26] .
Pharmacological inhibitors of PARP-1 and -2 were also demonstrated to be novel therapeutic targets for the treatment of several cancer types including LC [12, [21] [22] [23] [24] [27] [28] [29] [30] [31] .
Furthermore, the association of PARP inhibitors with cisplatin also showed to have additive effects on the treatment of LC as well as cervical, liver, and testicular cancers [27, 28, [30] [31] [32] .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 
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The precise mechanisms whereby PARP-1 and -2 inhibitors may reduce tumor size and growth remain to be fully understood.
Oxidative stress, defined as the imbalance between oxidant production and antioxidant activity in favor of the former is involved in the pathophysiology of a wide range of acute and chronic conditions including LC [33] [34] [35] [36] . For instance, several mechanisms led to increased oxidative stress in LC tumorogenesis, resulting in the accumulation of reactive oxygen species (ROS) such as hydroxyl radicals and superoxide anion [35, 37] . Besides, oxidative stress also triggers several responses in cells that may trigger autophagy [38, 39] and cell death [40] . Enhanced oxidative stress also induced DNA damage in tumor cells, which involved the activation of PARP-1 and PARP-2 molecules [15, 41] , and miR-223 targets PARP-1 expression in cancer [42] and other conditions [43] . Collectively, these mechanisms it could be used as a potential target mechanism in cancer therapy. Moreover, overactivation of PARP-1 through increased oxidative stress was also shown to promote apoptosis and necrosis in cells [44, 45] . Recent evidence also indicates that PARP-1 activation favors autophagy through enhanced oxidative stress in in vitro models [46, 47] . Unpublished observations from our group have recently shown that levels of several markers of oxidative stress were increased in the subcutaneous tumors of lung adenocarcinoma cells in mice. Additionally, the size of the tumors was significantly reduced and several markers of tumor growth were decreased in mice that were genetically deficient for either PARP-1 or -2 bearing the same lung adenocarcinoma [48] .
On the basis of these observations, we hypothesized that inhibition of either PARP-1 or -2 expressions in the host animals may influence tumor burden through several biological mechanisms such as redox imbalance (increased oxidative stress and/or reduced antioxidants and several cell regulators), autophagy, and apoptosis in the wild type lung adenocarcinoma cells. We reasoned that as it happens in patients receiving anticancer therapies, the host is likely to play a relevant role in tumor growth and progression regardless of the cancer 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5 microenvironment and cell differentiation degree [49] . Accordingly, the main objectives in the current investigation were to assess in the lung adenocarcinoma tumors of Parp-1 -/-and Parp-2 -/-mice, the levels of oxidative stress, antioxidant enzymes, apoptosis, autophagy, and cell proliferation rates compared to tumors in wild type (WT) animals. 
METHODS

In vivo measurements in the mice
Body weight and food intake were measured every day during the 30 days of the study period.
Moreover, food and water were supplied ad libitum for the entire duration of the study protocol.
Sacrifice and sample collection
On day 30 post-inoculation of LP07 tumor cells, animals from all experimental groups were sacrificed immediately after an intraperitoneal injection of 0.1 mL sodium pentobarbital (60 mg/Kg). The subcutaneous tumors were obtained subsequently afterwards. In all mice, tumor weights were determined using a high-precision scale. Frozen tumors were used for immunoblotting techniques, while paraffin-embedded tumors were used for immunohistochemical experiments.
Tumor biology analyses
Immunoblotting of 1D electrophoresis.
Protein levels of the different molecular markers and loading controls ( Figures E1-E3 ) analyzed in the current investigation were evaluated according to methodologies published elsewhere [53] .
Immunohistochemistry.
In the tumor specimens from all groups, the cell proliferation marker ki-67 was identified on the three-micrometer tumor paraffin-embedded sections using an specific antibody and immunohistochemical procedures as previously described in our group [36] . In addition, the number of positively stained nuclei for Ki-67 was counted in tumors from all animal groups. Data are expressed as the percentage of positively-stained nuclei in each tumor from the three experimental groups of mice. RNA concentrations were determined spectrophotometrically using the NanoDrop 1000 (Thermo Scientific, Waltham, MA, USA).
MicroRNA reverse transcription (RT).
MicroRNA RT was performed using TaqMan microRNA assays (Life Technologies) following the manufacturer's instructions.
Quantitative real time-PCR amplification (qRT-PCR). TaqMan based qPCR reactions
were performed using the ABI PRISM 7900HT Sequence Detector System (Applied BioSystems, Foster City, CA, USA) together with a commercially available predesigned microRNA assay, primers, and probes (Tables 1 and 2) , and published methodologies were followed [48] .
Statistical analyses
All statistical analyses were performed using the software Statistical Package for the Social 
RESULTS
Physiologic characteristics of mice
At the end of the study period (day 30), WT animals bearing the lung adenocarcinoma tumors exhibited a significant reduction in body weight gain (Table 3) . However, in LC-Parp-1 -/-and LC-Parp-2 -/-animals, body weight gain significantly increased compared to LC-WT (Table   3) . Importantly, the expression of both PARP-1 and PARP-2 was confirmed in the (Table 3 and Figures 1A-1C ).
Redox balance markers
Oxidative stress markers.
No significant differences were found in total protein tyrosine nitration levels in the tumors between either LC-Parp-1 -/-or LC-Parp-2 -/-mice and LC-WT animals ( Figure 2A and Figure E4 ). However, total MDA-protein adduct levels were significantly increased in the tumors of both LC-Parp-1 -/-and LC-Parp-2 -/-mice compared to LC-WT animals (Figures 2B and E5). 
Antioxidant enzymes. Compared to LC-WT animals
Apoptosis and autophagy markers
Bax protein levels were increased in the tumors of both LC-Parp 
Signaling regulators: expression of miR-223, NFATc-2 and HIF-1α
Expression of miR-223 was significantly decreased in the tumors of both LC-Parp-1 -/-and LC-Parp-2 -/-mice compared to LC-WT animals ( Figure 6A ). The expression of nuclear factor of activated T cells (NFAT)c-2 was significantly reduced only in the tumors of LC-Parp-1 -/-rodents compared to LC-WT mice ( Figure 6B ). Nevertheless, no significant differences in hypoxia-induced factor (HIF)-1α expression were observed in the tumors of the different study groups of mice ( Figure 6C ).
DISCUSSION
The main findings in the current investigation were that in the subcutaneous WT tumors of Parp-1 -/-and Parp-2 -/-mice compared to those analyzed in the WT animals: 1) tumor burden, as measured by weight, and cell proliferation rates were decreased; 2) oxidative stress levels were greater, whereas those of the major antioxidant enzymes were lower, especially those of catalase; 3) tumor apoptosis and autophagy levels were significantly increased, and 4) expression of miR-223 and NFATc-2 was decreased (the latter only in LC-Parp-1 -/-rodents).
Furthermore, whole body weight gain at the end of the study period also improved in Parp-1 -/-and Parp-2 -/-mice compared to the WT animals. These findings confirm the study hypothesis to a great extent.
Specific genetic deletions of PARP-1 and PARP-2 in the host mice induced a reduction in tumor growth as well as a decrease in cell proliferation, as measured by the ki-67
marker. In line with these results, in lung cancer xenografts, the combination of radiotherapy with PARP-1 inhibitors also promoted a tumor growth delay [54, 55] and a reduction of Ki-67 proliferation rates [54] . In addition, in a recent study, the combination of selective epidermal growth factor receptor (EGFR) and PARP-1 inhibitors also blocked tumor growth in ovarian cancer xenografts [56] . Moreover, the suppression of PARP-1 activity also resulted in a reduction of primary prostate tumor cell proliferation [25] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 Interestingly, PARP-1 and PARP-2 seem to have important roles in DNA repair in response to oxidative stress [15, 41] . These findings are in agreement with another study in which inhibition of PARP activity in HT22 tumor cells increased oxidative stress markers as quantified by protein carbonyls and oxidized DNA [41] . Moreover, recent data from our group (unpublished observations) and others [57] have shown a significant reduction in levels of the antioxidant catalase in tumor lesions of patients with several cancer types including LC. Indeed, the decrease in catalase in this investigation was suggested to be a potential biomarker for lung cancer progression in the patients [57] . In addition, a substantial decrease in several oxidative stress markers was also shown in the lung adenocarcinoma tumors of WT mice treated with antioxidants (unpublished observations).
The precise mechanisms whereby the absence of PARP-1 and -2 may induce a decrease in antioxidant expression in this in vivo model will be the focus of future research.
Nonetheless, in view of the current findings and previous observations [58, 59] on the   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 potential role of PARP in the modulation of oxidant production and antioxidant activity, it could be assumed that PARP-1 and -2 genetic inhibition in the mice may have antioxidant activity that could induce a downregulation of antioxidant enzymes such as catalase and SODs within the tumor cells. In fact, pharmacological PARP inhibitors showed antioxidant activity through directly scavenging oxidant production in vitro [58] . In keeping with, in another study [59] , overexpression of SODs was shown to prevent PARP expression and vice versa of neuronal cell death in a model of severe hypoglycemia. Collectively, it is possible to conclude from all the reported findings that PARP activity regulates the expression of major antioxidant systems in cells (SODs and catalase), thus inducing modifications in final oxidative stress balance that could be a target for anticancer treatment.
Importantly, oxidative stress also triggers different responses in cells such as cell death, e.g. apoptosis, and autophagy [60] . In the present study, the proapoptotic marker bax was increased, whereas levels of the anti-apoptotic bcl-2 were lower in the subcutaneous tumors of LC-Parp-1 -/-and LC-Parp-2 -/-mice than in tumors of the WT animals. These results suggest an increase in apoptotic events of tumor cells in Parp-1 -/-and Parp-2 -/-cancer bearing animals, which may partly account for the reduced tumor burden detected in these mice.
Interestingly, such findings are also in line with previous studies, in which PARP-1 inhibitors were shown to induce cell death through apoptotic mechanisms in lung cancer cell lines [54, 61] . Moreover, in one of these studies [54] , levels of apoptosis enhanced as a result of PARP-1 inhibition in lung tumor xenografts exposed to radiotherapy. Other investigations have also shown an induction of apoptosis in response to PARP inhibitors in several tumor cell types such as malignant gliomas, HeLa, and myeloid leukemia [62] [63] [64] .
In the current investigation, levels of the autophagy key regulator LC3-I/LC3-II were increased in the tumors of Parp-1 -/-and Parp-2 -/-mice compared to those detected in the tumors of the WT animals. Hence, it can be assumed that increased autophagy levels induced by PARP-1 and -2 genetic deletions may partly account for the reduced tumor burden 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 12 observed in the knockout animals compared to those in the WT mice. Interestingly, the current study findings are also in agreement with those encountered in a previous investigation, in which PARP-1 and PARP-2 inhibitors reduced tumor burden of ovarian cancer xenografts [56] and irradiated lung cancer cell lines [54] through the enhancement of autophagy.
The deacetylase enzyme sirtuin-1 may regulate upstream the LC3 pathway, thus playing a role in autophagy [65] . However, in the current study, protein levels of sirtuin-1
were found not to differ significantly in the lung adenocarcinoma tumors between WT and either Parp-1 -/-or LC-Parp-2 -/-mice. As the activation of sirtuin-1 requires the phosphorylation of several upstream molecules and cyclins [66] , it is likely that this process may have not taken place in the tumor cells of the animals. Interestingly, PARP-1 inhibition was shown to induce a decrease in sirtuin-1 levels in fibroblasts exposed to cigarette smoke [67] . However, greater sirtuin-1 levels were shown in Parp-1 -/-and in Parp-2 -/-mouse muscles in response to PARP inhibition [68, 69] . Therefore, the implications of sirtuin-1 in PARP-1 and PARP-2 inhibition are still controversial and will be further elucidated in future research.
Another interesting finding was the downregulation observed in the expression of miR-223 in the tumors of both Parp-1 -/-and LC-Parp-2 -/-mice compared to wild type animals.
Indeed, miR-223 has been recently shown to regulate PARP-1 expression in a model of pulmonary hypertension [43] . Furthermore, miR-223 was also shown to downregulate PARP-1 expression in patients with esophageal adenocarcinoma, and this mechanism was directly involved in the increased sensitivity of the cancer cells to chemotherapy [42] . Collectively, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   13 previously reported, in which PARP-1 activation was shown to upregulate the expression of several signaling molecules including NFATc-2 and HIF-1 alpha in pulmonary hypertension [70] . Taken together, it would be possibly suggested that another feedback loop may also exist between PARP-1 and NFATc-2 expressions in this model of adenocarcinoma.
Finally, it should also be discussed that cell growth and progression, as measured by 
Study limitations
In the study, tumor weights were only measured on day 30 of the study protocol, when all animals were sacrificed. Nevertheless, we believe that this is not a major limitation, since tumors were monitored and obtained under identical experimental conditions in the three experimental groups of mice.
Conclusions
We conclude from this study that PARP-1 and -2 genetic deletions in the host mice induced a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 tumor burden of mouse models of LC that could be eventually applied in actual clinical settings. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15
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GAPDH, glyceraldehyde-3-phosphate dehydrogenase; and g1, multi-exonic gene assay may detect genomic DNA if presenting the sample. Tables   Table 3. Body weights 
Gene Symbol Assay ID GeneBank accession number
